We are live on ! Find out more
BCAB icon

BioAtla

76 hedge funds and large institutions have $897M invested in BioAtla in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

23% more funds holding

Funds holding: 6276 (+14)

11% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 18

0.13% more ownership

Funds ownership: 1.18%1.32% (+0.13%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

7% less capital invested

Capital invested by funds: $964M → $897M (-$67.5M)

Holders
76
Holders Change
+14
Holders Change %
+22.58%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
20
Reduced
18
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PIM
26
Platinum Investment Management
Australia
$1.43M
MWNA
27
Marshall Wace North America
New York
$1.32M +$1.41M +623 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.31M -$38.4K -17 -3%
Fidelity International
29
Fidelity International
Bermuda
$1.16M +$1.24M +547 New
Rafferty Asset Management
30
Rafferty Asset Management
New York
$1.08M +$1.15M +509 New
Swiss National Bank
31
Swiss National Bank
Switzerland
$763K +$813K +360 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$713K -$29.4K -13 -4%
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$661K
AllianceBernstein
34
AllianceBernstein
Tennessee
$606K +$447K +198 +225%
Morgan Stanley
35
Morgan Stanley
New York
$591K +$630K +279 New
BFM
36
Boothbay Fund Management
New York
$508K +$111K +49 +26%
JF
37
Jump Financial
Illinois
$491K +$524K +232 New
Goldman Sachs
38
Goldman Sachs
New York
$485K -$380K -168 -42%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$474K +$199K +88 +65%
Bank of America
40
Bank of America
North Carolina
$461K +$79.1K +35 +19%
Victory Capital Management
41
Victory Capital Management
Texas
$454K -$24.9K -11 -5%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$445K -$13.6K -6 -3%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$370K +$395K +175 New
JP Morgan Chase
44
JP Morgan Chase
New York
$356K -$3.24M -1,434 -90%
Squarepoint
45
Squarepoint
New York
$336K +$357K +158 New
DY
46
Dowling & Yahnke
California
$322K +$343K +152 New
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$296K +$29.4K +13 +10%
OC
48
Oppenheimer & Co
New York
$247K
CS
49
Credit Suisse
Switzerland
$240K +$255K +113 New
VEA
50
Virtus ETF Advisers
New York
$237K +$253K +112 New

BCAB Hedge Fund Activity: Q2 2021 in Review

76 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q2 2021, worth a combined $897M — down 7% from $964M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new BCAB positions and 8 closed out — a net gain of 14 holders — while 20 added to existing stakes and 18 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $38.7M. The largest seller was Farallon Capital Management, cutting an estimated $26.7M.

  • 76 institutional investors held BioAtla (BCAB) as of Q2 2021, up from 62 in Q1 2021.
  • Funds reported $897M of BioAtla stock for Q2 2021, down 7% quarter-over-quarter.
  • 22 funds opened new BioAtla positions in Q2 2021 and 8 closed out, a net change of +14 holders.
  • The largest BioAtla buyer in Q2 2021 was Wellington Management Group, an estimated $38.7M added.
  • The largest BioAtla seller in Q2 2021 was Farallon Capital Management, an estimated $26.7M sold.

Based on aggregated 13F filings for Q2 2021.